Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Incyte Corp

Incyte Corp reported $223K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Aceragen Inc IDRA:US USD 4K 55K
Agenus AGEN:US USD 3.42M 361K
Agios Pharmaceuticals AGIO:US USD 72K 1000
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Bluebird Bio BLUE:US USD 1.06M 234K
CTI Biopharma CTIC:US USD 132K 1000
Eli Lilly LLY:US USD 593.5M 600K
Exelixis EXEL:US USD 325K 1000
Incyte Corp INCY:US USD 223K 0
Intercept Pharmaceuticals ICPT:US USD 42K 0
Ionis Pharmaceuticals IONS:US USD 143K 1000
Lumos Pharma Inc. NLNK:US USD 81K 1000
MacroGenics MGNX:US USD 618K 1000
Mirati Therapeutics MRTX:US USD 58K 0
Moderna Inc MRNA:US USD 38.4K 100
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 842M 48M
Novartis NVS:US USD 842M 48M
PTC Therapeutics PTCT:US USD 73K 1000
Puma Biotechnology PBYI:US USD 5K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 0
Ultragenyx Pharmaceutical RARE:US USD 71K 1000
Vertex Pharmaceuticals VRTX:US USD 2.6M 0